Afghanistan vs Madagascar: Access to anti-retroviral drugs, male
Afghanistan
7.0%
in 2024
Madagascar
22.0%
in 2024
Afghanistan rank
141st
Madagascar rank
139th
Access to anti-retroviral drugs, male over time
- Afghanistan
- Madagascar
How they compare
Madagascar currently reports 22.0% against 7.0% in Afghanistan, a difference of 15.0%.
That makes Madagascar's figure about 3.1 times Afghanistan's.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Madagascar ahead.
Afghanistan ranks 141st and Madagascar ranks 139th of 141 countries.
Across the 3 decades both report, Afghanistan averaged higher in 1 and Madagascar in 2.
Head to head by decade
| Decade | Afghanistan | Madagascar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.4% | 0.4% | Madagascar |
| 2010s | 4.7% | 3.4% | 1.3% | Afghanistan |
| 2020s | 7.4% | 15.0% | 7.6% | Madagascar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Afghanistan or Madagascar?
- Madagascar, at 22.0% against 7.0% in Afghanistan as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Afghanistan and Madagascar?
- 15.0%, with Madagascar ahead.
- How many years of comparable data are there for Afghanistan and Madagascar?
- 25 years are reported by both, from 2000 to 2024.
- How do Afghanistan and Madagascar rank globally for access to anti-retroviral drugs, male?
- Afghanistan ranks 141st and Madagascar ranks 139th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.